+948.4%
MRNA vs CBRE
+195.4%
+753.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CBRE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -0.9% | -1.7% |
| 7D | -12.7% | -4.8% | -7.9% | -11.0% |
| 30D | -20.7% | -5.9% | -14.8% | -18.5% |
| 3M | +46.3% | -16.5% | +62.8% | +56.8% |
| 6M | +305.2% | -3.4% | +308.6% | +322.1% |
| YTD | +561.2% | -21.2% | +582.4% | +624.6% |
| 1Y | +772.1% | -16.4% | +788.5% | +842.6% |
| 3Y | +147.0% | +62.2% | +84.7% | +133.2% |
| 5Y | -26.1% | +27.1% | -53.2% | -30.0% |
| All | +948.4% | +195.4% | +753.0% | +714.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CBRE.
Daily Out/Under-Performance
Portfolio return minus CBRE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CBRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CBRE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling